Ws Portfolio Advisory, LLC Royalty Pharma PLC Transaction History
Ws Portfolio Advisory, LLC
- $671 Billion
- Q1 2024
A detailed history of Ws Portfolio Advisory, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ws Portfolio Advisory, LLC holds 396,342 shares of RPRX stock, worth $10.2 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
396,342
Previous 479,248
17.3%
Holding current value
$10.2 Million
Previous $13.5 Billion
10.59%
% of portfolio
1.79%
Previous 2.49%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.06 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$970 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$594 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$416 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$312 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...